Cannabis Report in text over top a photo of cannabis leaves
(Source: File)

A leading international provider of consumer cannabis products, today announced the launch of Anthem Bold, a new infused pre-roll line that expands the company’s growing Anthem brand portfolio. Anthem Bold is now available exclusively at its dispensaries in Arizona, Illinois, New Jersey and New York, with a wholesale launch to follow.

(Anthem Bold. Source: Curaleaf Holdings, Inc.)

Click here for the full story.

Weekly Update – Top Cannabis News Stories

1 | High Tide makes annual ranking of Canada’s top growing companies for fifth consecutive year

2 | Cannabix Technologies announces first sale of BreathLogix alcohol screening device to Maritime market

3 | Curaleaf announces executive automatic securities disposition plan


Top Cannabis Stocks Sept. 26. to Oct. 2, 2025

1. T.TLRY | 7,390 views | Tilray Brands Inc.
2. T.CURA| 5,354 views | Curaleaf Holdings Inc.
3. T.WEED | 3,909 views | Canopy Growth Corp.
4. T.LABS | 2,510 views | Medipharm Labs Corp.
5. T.OGI | 674 views | Organigram Global Inc.
6. T.ACB | 615 views | Aurora Cannabis Inc.


Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein. For full disclaimer information, please click here.


More From The Market Online

@ the Bell: TSX lifted by strong earnings from Big Six banks

The TSX Index added more than 1 per cent on Thursday driven by strong earnings from Canada’s Big Six banks.

Market Open: Salesforce Gains, EQB Buys PC Financial, Copper Slips | Dec 04, 2025

TSX rises 0.36% as Salesforce jumps 2% and EQB acquires PC Financial. Dow dips, gold edges higher, copper and Bitcoin fall.

Buzz on the Bullboards: Cannabis stock split, major financing, and battery breakthrough

Inflation concerns, lofty valuations, and growing uncertainty around returns from have prompted investors to reassess their AI exposure.